Welcome to our dedicated page for Peraso SEC filings (Ticker: PRSO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Peraso Inc. (NASDAQ: PRSO) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures, drawn from the U.S. Securities and Exchange Commission’s EDGAR system. Peraso is a fabless semiconductor company focused on 60 GHz unlicensed and 5G mmWave wireless technology, and its filings offer detailed insight into its capital structure, governance, financing activities and financial performance.
Investors can review Form 10‑K annual reports and Form 10‑Q quarterly reports to understand how Peraso describes its business, risk factors and results of operations, including its focus on mmWave chipsets, antenna modules, software and IP. These core filings typically include segment information, discussion of fixed wireless access and other applications, and management’s analysis of revenue, expenses and non-GAAP metrics.
Peraso’s frequent Form 8‑K current reports document material events such as earnings releases, strategic review updates, prospectus supplements for at-the-market equity offerings, changes in outstanding securities, and governance matters. For example, 8‑K filings describe the company’s ongoing strategic review and interactions with Mobix Labs, amendments to its Amended and Restated 2019 Stock Incentive Plan, the appointment of director Cees Links, and notices related to regaining compliance with Nasdaq’s minimum bid price requirement.
This page also surfaces registration statements and prospectus supplements that outline Peraso’s at-the-market offering program, as well as disclosures on outstanding warrants, stock options, restricted stock units and the Series A special voting preferred stock. Where available, Form 4 insider transaction reports can be used to track equity transactions by directors and officers.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify items such as changes in capital structure, non-GAAP reconciliations, board and committee changes, and updates on strategic alternatives. Real-time updates ensure that new Peraso filings appear promptly, giving investors an efficient way to follow the company’s regulatory history and ongoing reporting.
Peraso Inc. (PRSO) filed a Form D reporting a completed Regulation D offering totaling $1,288,809. The filing states the offering involved equity and related warrants: 952,380 shares issuable upon exercise of Series E warrants at $1.25 per share and 66,667 shares issuable upon exercise of placement agent warrants at $1.475 per share.
The offering was conducted under Rule 506(b) with a reported first sale date of 2025-09-11 and shows a single investor participated. Ladenburg Thalmann & Co. Inc. is listed as the broker-dealer, sales commissions are reported as $244,477 (estimate), and the issuer indicates $0 of the proceeds were used to pay executive officers, directors or promoters.
Peraso Inc. (PRSO) filed a Form D reporting a completed Regulation D offering totaling $1,288,809. The filing states the offering involved equity and related warrants: 952,380 shares issuable upon exercise of Series E warrants at $1.25 per share and 66,667 shares issuable upon exercise of placement agent warrants at $1.475 per share.
The offering was conducted under Rule 506(b) with a reported first sale date of 2025-09-11 and shows a single investor participated. Ladenburg Thalmann & Co. Inc. is listed as the broker-dealer, sales commissions are reported as $244,477 (estimate), and the issuer indicates $0 of the proceeds were used to pay executive officers, directors or promoters.
Peraso Inc. reported that it has regained compliance with the Nasdaq Capital Market’s minimum bid price requirement. The company received a notification letter from Nasdaq’s Listing Qualifications Department on September 19, 2025, confirming that it again meets the minimum bid price standard under Nasdaq Listing Rule 5550(a)(2). A press release dated September 22, 2025 providing further detail is included as an exhibit to this report.
Peraso Inc. reported that it has regained compliance with the Nasdaq Capital Market’s minimum bid price requirement. The company received a notification letter from Nasdaq’s Listing Qualifications Department on September 19, 2025, confirming that it again meets the minimum bid price standard under Nasdaq Listing Rule 5550(a)(2). A press release dated September 22, 2025 providing further detail is included as an exhibit to this report.
Peraso Inc. reported that it is continuing its strategic review and has received a revised unsolicited proposal from Mobix Labs, Inc. to acquire the company using both cash and stock consideration in an undetermined amount. Peraso has invited Mobix Labs to join a limited exploratory call, structured so that Peraso does not share material non-public information and does not operate under a confidentiality agreement. The call, if held on these or other mutually acceptable terms, would help Peraso better understand Mobix Labs’ updated proposal and intentions, but no transaction has been agreed.
Peraso Inc. received a notice from Nasdaq that its common stock no longer meets the minimum bid price requirement of $1 per share. This determination was based on the stock’s closing bid price over 30 consecutive business days ending September 4, 2025.
The company has 180 calendar days, until March 4, 2026, to regain compliance. To do so, its stock must close at or above $1 per share for at least ten consecutive business days during this period. If it fails, Peraso may qualify for an additional 180-day extension if it meets other Nasdaq Capital Market standards and notifies Nasdaq of plans to cure the deficiency, potentially through a reverse stock split.
The notice does not cause immediate delisting, but Peraso’s common stock could be removed from the Nasdaq Capital Market if it cannot restore compliance. The company states it is monitoring its share price and evaluating its options.
Peraso Inc. filed a current report to note that it has issued a new press release updating its ongoing strategic review process. The update also covers developments related to an unsolicited, non-binding proposal from Mobix Labs, Inc., which Peraso had first disclosed on June 27, 2025. The press release dated August 19, 2025 is included as an exhibit and incorporated by reference, indicating that further details on the review and the proposal are contained in that document.
Peraso Inc. received a Schedule 13G/A in which Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page report warrants and beneficial ownership rights for Peraso common stock. The filing discloses reported securities to purchase a combined 1,428,570 shares, with reported allocations of 371,424 shares to Iroquois, 1,057,146 shares attributable solely to Mr. Abbe and 371,424 shares attributable to Ms. Page, and shows shared interests of 371,424 shares among the parties.
The filing states the percentages were calculated using 5,027,173 shares outstanding and reports 9.99% for Mr. Abbe and 6.88% for Iroquois and Ms. Page. The reported warrants are subject to a 9.99% blocker, and the cover-page counts reflect shares issuable upon full exercise without applying the blocker, meaning the actual exercisable ownership will be lower. The filers certify these securities were not acquired to change or influence control of the issuer.
Peraso Inc. reported total net revenue of $2.22 million for the quarter and $6.09 million for the six months ended June 30, 2025, with product sales shifting away from discontinued memory ICs toward mmWave ICs and antenna modules. The company recorded a net loss of $1.83 million for the quarter and $2.30 million for the six months, and had cash and cash equivalents of $1.76 million and an accumulated deficit of approximately $179.4 million as of June 30, 2025.
The company completed final end-of-life shipments for its memory ICs in March 2025, reported improved six-month gross profit driven by mmWave product sales, reduced R&D and SG&A costs, and raised proceeds from at-the-market sales. The board has launched a strategic review after receiving an unsolicited, non-binding proposal from Mobix Labs and is pursuing additional financings. Management and the auditor have expressed substantial doubt about the company’s ability to continue as a going concern without additional capital.
Peraso Inc. (PRSO) Chief Technology Officer Alex Tomkins was granted a stock option to purchase 25,000 shares on August 7, 2025 with an exercise price of $0.8399. The option is reported as direct beneficial ownership of 25,000 derivative securities and the filing shows the option price reported as $0.00 in the form's table.
The option vests as to 1/36th of the shares on each monthly anniversary following August 7, 2025. The Form 4 was signed by James Sullivan by power of attorney on August 11, 2025. The filing does not disclose total shares outstanding or the percentage this grant represents, so materiality relative to the company's equity cannot be determined from this Form 4 alone.
James Sullivan, Chief Financial Officer of Peraso Inc. (PRSO), reported acquisition of stock options granting the right to purchase 25,000 shares of common stock at an exercise price of $0.8399 per share, with a transaction date of 08/07/2025. The options vest at 1/36th of the shares on each monthly anniversary following 08/07/2025 and are reported as held directly by the reporting person. The filing lists a date of 08/07/2035 in the date/exercise expiration field and reports total derivative holdings of 25,000 options. The explanation clarifies the monthly vesting schedule and notes that column reporting covers only the listed derivative class.
Brad Lynch, identified in the filing as the Chief Operating Officer of Peraso, Inc. (PRSO), reported receipt of a stock option grant on 08/07/2025. The award comprises 25,000 options to purchase common stock at an exercise price of $0.8399, with a stated expiration of 08/07/2035.
The option vests monthly at 1/36th of the shares following the grant date, the acquisition is reported as an “A” (acquired) transaction, and the filing shows 25,000 derivative securities beneficially owned following the transaction, held in a direct ownership form. The Form 4 was filed by one reporting person and includes explanatory notes on vesting and reporting conventions.